{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-008474","form_type":"8-K","ticker":"AVR","cik":"0002011514","company_name":"Anteris Technologies Global Corp.","filed_at":"2025-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.791788+00:00","generated_at":"2026-05-24T21:40:56.465665+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Anteris Technologies posts FY2024 net loss of $76M; auditor flags going concern doubt","bullets":["Net loss after tax $76.0M vs $46.8M in 2023; revenue flat at $2.7M.","Cash balance $70.5M at Dec 31, 2024, after US IPO net proceeds of ~$79.6M.","Net tangible asset backing per share $1.74 (Dec 2023: $1.04).","Auditor's report unmodified but includes Emphasis of Matter on going concern.","IDE submission for DurAVR THV pivotal trial on track for Q1 2025; 86 patients implanted to date."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-008474","json":"https://secwatch.observer/filing/0001140361-25-008474.json","markdown":"https://secwatch.observer/filing/0001140361-25-008474.md","text":"https://secwatch.observer/filing/0001140361-25-008474.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2011514/000114036125008474/0001140361-25-008474-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2011514/000114036125008474/ef20045173_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T21:40:56.465665+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}